A potential Sycamore buyout sounded like good news--until analysts revealed the brutal reality behind the deal.

Sycamore Partners’ potential bid to take Walgreens Boots Alliance (NASDAQ:WBA) private and split into three parts seems “highly difficult” which leads Deutsche Bank’s George Hill to see a more likely ...

Walgreens Boots (NASDAQ:WBA) fell 4.7% after a report that a Sycamore Partners deal for the drugstore chain is unlikely to have much of a premium. Sycamore is closing in on a deal for Walgreens ...

The deal is not yet finalized. Other news includes: tariffs on the pharmaceutical industry and what it means for medicine; Pfizer putting emphasis on merit in the face of DEI overhaul; and more.

The deal hype started in early-December, when the Wall Street Journal reported Walgreens was in talks to sell itself to Sycamore Partners. Read: Walgreens' stock could see its best day ever. Is a ...

Boots’ prospective buyer Sycamore Partners is planning to separate the UK retail pharmacy business from its US and healthcare ...

A rumored private equity buyout of Walgreens could lead the company to be split up, according to media reports. | A rumored ...

PE firm Sycamore Partners reportedly plans to split Walgreens Boots Alliance into three independent businesses if it successfully acquires the drugstore chain.

The private-equity suitor is planning on splitting up Walgreens' U.S. and U.K. pharmacy businesses, as well as its specialty ...

Sycamore Partners is eyeing a major Walgreens buyout--splitting the pharmacy giant into three. Will this rescue or wreck the ...

U.S. pharmacy retailer Walgreens, U.K.-based Boots and specialty unit Shields Health Solutions—could become three independent ...

Walgreens' three businesses - U.S. retail pharmacy, Boots UK and U.S. healthcare - will be separated and have distinct ...